Mill Capital Management
BSX icon

Mill Capital Management’s Boston Scientific BSX Stock Holding History

Mill Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10M Sell
230,129
-686
-0.3% -$31.8K 0.66% 34
2026
Q2 		$9.9M Buy
230,815
+81,059
+54% +$4.4M 0.66% 34
2026
Q1 		$9.4M Buy
149,756
+42,453
+40% +$3.4M 0.71% 33
2025
Q4 		$10.2M Buy
+107,303
New +$10.5M 0.74% 33

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Mill Capital Management's BSX Position: Q3 2026 in Review

Mill Capital Management reduced its Boston Scientific (BSX) stake by 0.3% in Q3 2026, selling an estimated $31.8K and leaving 230,129 shares worth $10M. The position accounts for 0.66% of the portfolio, ranked #34.

Mill Capital Management first reported a position in BSX in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.2M in Q4 2025. 558 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Mill Capital Management held 230,129 shares of Boston Scientific worth $10M as of Q3 2026.
  • Mill Capital Management sold 686 Boston Scientific shares in Q3 2026, an estimated $31.8K.
  • Boston Scientific made up 0.66% of Mill Capital Management's portfolio in Q3 2026, its #34 holding.
  • Mill Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 4 quarters since.
  • Mill Capital Management's Boston Scientific position peaked at $10.2M in Q4 2025.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.